State Street Corp Enanta Pharmaceuticals Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 449,975 shares of ENTA stock, worth $2.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

449,975

Previous 422,828 6.42%

Holding current value

$2.83 Million

Previous $5.48 Million 14.92%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.05 - $16.54 $272,827 - $449,011	27,147 Added 6.42%	449,975 $4.67 Million
Q2 2024 Aug 14, 2024	SELL	$11.43 - $17.02 $12,995 - $19,351	-1,137 Reduced 0.27%	422,828 $5.48 Million
Q1 2024 May 15, 2024	SELL	$10.08 - $17.46 $16,884 - $29,245	-1,675 Reduced 0.39%	423,965 $7.4 Million
Q4 2023 Feb 14, 2024	SELL	$8.18 - $10.78 $200,557 - $264,304	-24,518 Reduced 5.45%	425,640 $4.01 Million
Q3 2023 Nov 14, 2023	SELL	$11.09 - $22.13 $11.8 Million - $23.6 Million	-1,068,093 Reduced 70.35%	450,158 $5.03 Million
Q2 2023 Aug 14, 2023	BUY	$20.68 - $39.85 $6.56 Million - $12.6 Million	317,315 Added 26.42%	1,518,251 $32.5 Million
Q1 2023 May 15, 2023	SELL	$38.82 - $54.59 $12.1 Million - $17 Million	-311,256 Reduced 20.58%	1,200,936 $48.6 Million
Q4 2022 Feb 14, 2023	BUY	$40.77 - $53.73 $5.49 Million - $7.24 Million	134,775 Added 9.78%	1,512,192 $70.3 Million
Q3 2022 Nov 15, 2022	SELL	$48.29 - $71.27 $15.5 Million - $22.9 Million	-322,011 Reduced 18.95%	1,377,417 $71.4 Million
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $14.9 Million - $30.1 Million	390,842 Added 29.87%	1,699,428 $80.3 Million
Q1 2022 May 16, 2022	BUY	$56.06 - $74.11 $10.2 Million - $13.5 Million	181,517 Added 16.11%	1,308,586 $93.1 Million
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $3.3 Million - $5.34 Million	54,887 Added 5.12%	1,127,069 $84.3 Million
Q3 2021 Nov 15, 2021	BUY	$41.02 - $58.65 $742,749 - $1.06 Million	18,107 Added 1.72%	1,072,182 $60.9 Million
Q2 2021 Aug 16, 2021	SELL	$43.76 - $53.11 $1.93 Million - $2.34 Million	-44,049 Reduced 4.01%	1,054,075 $46.4 Million
Q1 2021 May 17, 2021	SELL	$41.69 - $54.95 $3.13 Million - $4.13 Million	-75,116 Reduced 6.4%	1,098,124 $54.2 Million
Q4 2020 Feb 16, 2021	BUY	$41.16 - $47.47 $8.63 Million - $9.96 Million	209,722 Added 21.77%	1,173,240 $49.4 Million
Q3 2020 Nov 10, 2020	SELL	$43.36 - $53.53 $4.14 Million - $5.12 Million	-95,578 Reduced 9.02%	963,518 $44.1 Million
Q2 2020 Aug 14, 2020	BUY	$46.37 - $57.58 $7.01 Million - $8.7 Million	151,172 Added 16.65%	1,059,096 $53.2 Million
Q1 2020 May 11, 2020	BUY	$40.22 - $62.0 $36.5 Million - $56.3 Million	907,924 New	907,924 $46.7 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $130M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Enanta Pharmaceuticals Inc Transaction History